YB-1 AP–CSD Forms Cross-β Amyloid Fibrils Without Secondary-Structure Conversion In Vitro
Abstract
1. Introduction
2. Results
2.1. Aggregation of the AP–CSD Fragment
2.2. DLS Analysis
2.3. AFM Analysis
2.4. 1H NMR Spectroscopy
2.5. Secondary Structure Analysis
2.6. Molecular Dynamics and Bioinformatics
3. Discussion
4. Materials and Methods
4.1. Protein Expression and Purification
4.2. Aggregation Conditions and Sample Preparation
4.3. X-Ray Diffraction Study
4.4. DLS Analysis
4.5. AFM Imaging
4.6. 1H NMR
4.7. CD Spectroscopy
4.8. Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy
4.9. Molecular Dynamics Simulations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
References
- Mordovkina, D.; Lyabin, D.N.; Smolin, E.A.; Sogorina, E.M.; Ovchinnikov, L.P.; Eliseeva, I. Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control. Biomolecules 2020, 10, 591. [Google Scholar] [CrossRef]
- Lyabin, D.N.; Eliseeva, I.A.; Ovchinnikov, L.P. YB-1 Protein: Functions and Regulation. Wiley Interdiscip. Rev. RNA 2014, 5, 95–110. [Google Scholar] [CrossRef]
- Wu, S.-L.; Fu, X.; Huang, J.; Jia, T.-T.; Zong, F.-Y.; Mu, S.-R.; Zhu, H.; Yan, Y.; Qiu, S.; Wu, Q.; et al. Genome-Wide Analysis of YB-1–RNA Interactions Reveals a Novel Role of YB-1 in miRNA Processing in Glioblastoma Multiforme. Nucleic Acids Res. 2015, 43, 8516–8528. [Google Scholar] [CrossRef]
- Lyabin, D.N.; Eliseeva, I.A.; Smolin, E.A.; Doronin, A.N.; Budkina, K.S.; Kulakovskiy, I.V.; Ovchinnikov, L.P. YB-3 Substitutes YB-1 in Global mRNA Binding. RNA Biol. 2020, 17, 487–499. [Google Scholar] [CrossRef] [PubMed]
- Yang, X.-J.; Zhu, H.; Mu, S.-R.; Wei, W.-J.; Yuan, X.; Wang, M.; Liu, Y.; Hui, J.; Huang, Y. Crystal Structure of a Y-Box Binding Protein 1 (YB-1)–RNA Complex Reveals Key Features and Residues Interacting with RNA. J. Biol. Chem. 2019, 294, 10998–11010. [Google Scholar] [CrossRef] [PubMed]
- Kloks, C.P.A.M.; Spronk, C.A.E.M.; Lasonder, E.; Hoffmann, A.; Vuister, G.W.; Grzesiek, S.; Hilbers, C.W. The Solution Structure and DNA-Binding Properties of the Cold-Shock Domain of the Human Y-Box Protein YB-1. J. Mol. Biol. 2002, 316, 317–326. [Google Scholar] [CrossRef]
- Kloks, C.P.; Tessari, M.; Vuister, G.W.; Hilbers, C.W. Cold Shock Domain of the Human Y-Box Protein YB-1: Backbone Dynamics and Equilibrium between the Native State and a Partially Unfolded State. Biochemistry 2004, 43, 10237–10246. [Google Scholar] [CrossRef]
- Guryanov, S.G.; Filimonov, V.V.; Timchenko, A.A.; Melnik, B.S.; Kihara, H.; Kutyshenko, V.P.; Ovchinnikov, L.P.; Semisotnov, G.V. The Major mRNP Protein YB-1: Structural and Association Properties in Solution. Biochim. Biophys. Acta 2013, 1834, 559–567. [Google Scholar] [CrossRef] [PubMed]
- Petrosian, S.A.; Makhatadze, G.I. Contribution of Proton Linkage to the Thermodynamic Stability of the Major Cold-Shock Protein of Escherichia coli CspA. Protein Sci. 2000, 9, 387–394. [Google Scholar] [CrossRef]
- Budkina, K.; El Hage, K.; Clément, M.-J.; Desforges, B.; Bouhss, A.; Joshi, V.; Maucuer, A.; Hamon, L.; Ovchinnikov, L.P.; Lyabin, D.N.; et al. YB-1 Unwinds mRNA Secondary Structures in vitro and Negatively Regulates Stress Granule Assembly in HeLa Cells. Nucleic Acids Res. 2021, 49, 10061–10081. [Google Scholar] [CrossRef]
- Horn, G.; Hofweber, R.; Kremer, W.; Kalbitzer, H.R. Structure and Function of Bacterial Cold Shock Proteins. Cell. Mol. Life Sci. 2007, 64, 1457–1470. [Google Scholar] [CrossRef]
- Maris, C.; Dominguez, C.; Allain, F.H.-T. The RNA Recognition Motif, a Plastic RNA-Binding Platform to Regulate Post-Transcriptional Gene Expression. FEBS J. 2005, 272, 2118–2131. [Google Scholar] [CrossRef]
- Schröder, K.; Graumann, P.; Schnuchel, A.; Holak, T.A.; Marahiel, M.A. Mutational Analysis of the Putative Nucleic Acid-Binding Surface of the Cold-Shock Domain, CspB, Revealed an Essential Role of Aromatic and Basic Residues in Binding of Single-Stranded DNA Containing the Y-Box Motif. Mol. Microbiol. 1995, 16, 699–708. [Google Scholar] [CrossRef]
- Selivanova, O.M.; Guryanov, S.G.; Enin, G.A.; Skabkin, M.A.; Ovchinnikov, L.P.; Serdyuk, I.N. YB-1 is capable of forming extended nanofibrils. Biochemistry 2010, 75, 115–120. [Google Scholar] [CrossRef] [PubMed]
- Guryanov, S.G.; Selivanova, O.M.; Nikulin, A.D.; Enin, G.A.; Melnik, B.S.; Kretov, D.A.; Serdyuk, I.N.; Ovchinnikov, L.P. Formation of amyloid-like fibrils by Y-box binding protein 1 (YB-1) is mediated by its cold shock domain and modulated by disordered terminal domains. PLoS ONE 2012, 7, e36969. [Google Scholar] [CrossRef]
- Zhang, J.; Fan, J.-S.; Li, S.; Yang, Y.; Sun, P.; Zhu, Q.; Wang, J.; Jiang, B.; Yang, D.; Liu, M. Structural basis of DNA binding to human YB-1 cold shock domain regulated by phosphorylation. Nucleic Acids Res. 2020, 48, 9361–9371. [Google Scholar] [CrossRef]
- Chiti, F.; Dobson, C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75, 333–366. [Google Scholar] [CrossRef]
- Eisenberg, D.; Jucker, M. The amyloid state of proteins in human diseases. Cell 2012, 148, 1188–1203. [Google Scholar] [CrossRef] [PubMed]
- Arosio, P.; Michaels, T.C.T.; Linse, S.; Månsson, C.; Emanuelsson, C.; Presto, J.; Johansson, J.; Vendruscolo, M.; Dobson, C.M.; Knowles, T.P.J. Kinetic Analysis Reveals the Diversity of Microscopic Mechanisms through Which Molecular Chaperones Suppress Amyloid Formation. Nat. Commun. 2016, 7, 10948. [Google Scholar] [CrossRef] [PubMed]
- Riek, R.; Eisenberg, D.S. The activities of amyloids from a structural perspective. Nature 2016, 539, 227–235. [Google Scholar] [CrossRef]
- Somasekharan, S.P.; El-Naggar, A.; Leprivier, G.; Cheng, H.; Hajee, S.; Grunewald, T.G.P.; Zhang, F.; Ng, T.; Delattre, O.; Evdokimova, V.; et al. YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1. J. Cell Biol. 2015, 208, 913–929. [Google Scholar] [CrossRef]
- Li, Y.R.; King, O.D.; Shorter, J.; Gitler, A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013, 201, 361–372. [Google Scholar] [CrossRef]
- Vanderweyde, T.; Youmans, K.; Liu-Yesucevitz, L.; Wolozin, B. Role of stress granules and RNA-binding proteins in neurodegeneration: A mini-review. Gerontology 2013, 59, 524–533. [Google Scholar] [CrossRef]
- Toyoshima, Y.; Takahashi, H. TDP-43 Pathology in Polyglutamine Diseases: With Reference to Amyotrophic Lateral Sclerosis. Neuropathology 2014, 34, 77–82. [Google Scholar] [CrossRef]
- Ruysschaert, J.-M.; Raussens, V. ATR-FTIR Analysis of Amyloid Proteins. Methods Mol. Biol. 2018, 1777, 69–81. [Google Scholar] [CrossRef] [PubMed]
- Garbuzynskiy, S.O.; Lobanov, M.Y.; Galzitskaya, O.V. FoldAmyloid: A Method of Prediction of Amyloidogenic Regions from Protein Sequence. Bioinformatics 2010, 26, 326–332. [Google Scholar] [CrossRef]
- Walsh, I.; Seno, F.; Tosatto, S.C.E.; Trovato, A. PASTA 2.0: An Improved Server for Protein Aggregation Prediction. Nucleic Acids Res. 2014, 42, W301–W307. [Google Scholar] [CrossRef]
- Conchillo-Solé, O.; de Groot, N.S.; Avilés, F.X.; Vendrell, J.; Daura, X.; Ventura, S. AGGRESCAN: A Server for the Prediction and Evaluation of “Hot Spots” of Aggregation in Polypeptides. BMC Bioinform. 2007, 8, 65. [Google Scholar] [CrossRef]
- Maurer-Stroh, S.; Debulpaep, M.; Kuemmerer, N.; Lopez de la Paz, M.; Martins, I.C.; Reumers, J.; Morris, K.L.; Copland, A.; Serpell, L.; Serrano, L.; et al. Exploring the Sequence Determinants of Amyloid Structure Using Position-Specific Scoring Matrices (WALTZ). Nat. Methods 2010, 7, 237–242. [Google Scholar] [CrossRef] [PubMed]
- Abramson, J.; Adler, J.; Dunger, J.; Evans, R.; Green, T.; Pritzel, A.; Ronneberger, O.; Willmore, L.; Ballard, A.J.; Bambrick, J.; et al. Accurate Structure Prediction of Biomolecular Interactions with AlphaFold 3. Nature 2024, 630, 493–500. [Google Scholar] [CrossRef] [PubMed]
- Morris, A.M.; Watzky, M.A.; Agar, J.N.; Finke, R.G. Fitting neurological protein aggregation kinetic data via a 2-step, minimal/“Ockham’s razor” model: The Finke–Watzky mechanism of nucleation followed by autocatalytic surface growth. Biochemistry 2008, 47, 2413–2427. [Google Scholar] [CrossRef]
- Arosio, P.; Knowles, T.P.J.; Linse, S. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 2015, 17, 7606–7618. [Google Scholar] [CrossRef] [PubMed]
- Crespo, R.; Rocha, F.A.; Damas, A.M.; Martins, P.M. A generic crystallization-like model that describes the kinetics of amyloid fibril formation. J. Biol. Chem. 2012, 287, 30585–30594. [Google Scholar] [CrossRef] [PubMed]
- Serpell, L.C.; Fraser, P.E.; Sunde, M. X-Ray Fiber Diffraction of Amyloid Fibrils. Methods Enzymol. 1999, 309, 526–536. [Google Scholar] [CrossRef]
- Sreerama, N.; Woody, R.W. Estimation of Protein Secondary Structure from Circular Dichroism Spectra: Comparison of CONTIN, SELCON, and CDSSTR Methods with an Expanded Reference Set. Anal. Biochem. 2000, 287, 252–260. [Google Scholar] [CrossRef]
- Wang, J.; Wolf, R.M.; Caldwell, J.W.; Kollman, P.A.; Case, D.A. Development and Testing of a General Amber Force Field. J. Comput. Chem. 2004, 25, 1157–1174. [Google Scholar] [CrossRef]
- Mahoney, M.W.; Jorgensen, W.L. A Five-Site Model for Liquid Water and the Reproduction of the Density Anomaly by Rigid, Nonpolarizable Potential Functions. J. Chem. Phys. 2000, 112, 8910–8922. [Google Scholar] [CrossRef]
- Likhachev, I.V.; Balabaev, N.K.; Galzitskaya, O.V. Available Instruments for Analyzing Molecular Dynamics Trajectories. Open Biochem. J. 2016, 10, 1–11. [Google Scholar] [CrossRef]









| CD | α, % | β, % Antiparallel | β, % Parallel | Turn, % | Other |
|---|---|---|---|---|---|
| 0 h aggregation | 0.4 ± 0.3 | 34.2 ± 1.7 | 0.0 | 17.5 ± 0.9 | 47.9 ± 2.4 |
| 10 h aggregation | 2.8 ± 0.3 | 32.7 ± 1.6 | 0.0 | 18.1 ± 0.9 | 46.4 ± 2.3 |
| 82 h aggregation | 0.0 ± 0.3 | 31.9 ± 2.6 | 0.0 | 16.4 ± 1.3 | 51.6 ± 4.1 |
| ATR-FTIR | α, % | β, % | RC, % | ||
| 82 h aggregation | 12 ± 3 | 36 ± 7 | 52 ± 8 | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Timchenko, M.A.; Galzitskaya, O.V.; Chulkov, A.V.; Likhachev, I.V.; Glyakina, A.V.; Molchanov, M.V.; Molochkov, N.V.; Penkov, N.V.; Bobyleva, L.G.; Balobanov, V.A.; et al. YB-1 AP–CSD Forms Cross-β Amyloid Fibrils Without Secondary-Structure Conversion In Vitro. Int. J. Mol. Sci. 2026, 27, 3553. https://doi.org/10.3390/ijms27083553
Timchenko MA, Galzitskaya OV, Chulkov AV, Likhachev IV, Glyakina AV, Molchanov MV, Molochkov NV, Penkov NV, Bobyleva LG, Balobanov VA, et al. YB-1 AP–CSD Forms Cross-β Amyloid Fibrils Without Secondary-Structure Conversion In Vitro. International Journal of Molecular Sciences. 2026; 27(8):3553. https://doi.org/10.3390/ijms27083553
Chicago/Turabian StyleTimchenko, Maria A., Oxana V. Galzitskaya, Alexander V. Chulkov, Ilya V. Likhachev, Anna V. Glyakina, Maxim V. Molchanov, Nikolay V. Molochkov, Nikita V. Penkov, Liya G. Bobyleva, Vitalii A. Balobanov, and et al. 2026. "YB-1 AP–CSD Forms Cross-β Amyloid Fibrils Without Secondary-Structure Conversion In Vitro" International Journal of Molecular Sciences 27, no. 8: 3553. https://doi.org/10.3390/ijms27083553
APA StyleTimchenko, M. A., Galzitskaya, O. V., Chulkov, A. V., Likhachev, I. V., Glyakina, A. V., Molchanov, M. V., Molochkov, N. V., Penkov, N. V., Bobyleva, L. G., Balobanov, V. A., Yegorov, A. Y., Guryanov, S. G., Nikulin, A. D., Lyabin, D. N., Vikhlyantsev, I. M., & Bobylev, A. G. (2026). YB-1 AP–CSD Forms Cross-β Amyloid Fibrils Without Secondary-Structure Conversion In Vitro. International Journal of Molecular Sciences, 27(8), 3553. https://doi.org/10.3390/ijms27083553

